Biomedical Sciences

Unique Novel Drug Shows Promise Against SARS-CoV-2

April 30, 2024

Olgotrelvir (STI-1558) is a novel antiviral drug designed to address the challenges posed by the emergence of new, more infectious and virulent SARS-CoV-2 variants. This drug is particularly important for populations at risk who may not benefit from existing treatments like Paxlovid due to potential drug-drug interactions. Olgotrelvir exhibits strong antiviral activity against the SARS-CoV-2 main protease (Mpro), including its variants which showed resistant to Paxlovid. Furthermore, it inhibits human cathepsin L (CTSL), a host enzyme critical for viral entry through the endosomal pathway, thereby blocking both the entry and replication of the virus. Phase 1 clinical trials have demonstrated that oral administration of Olgotrelvir achieves effective plasma levels with limited mild adverse effects and a promising reduction in viral RNA load.

SARS-CoV-2 Spike Protein Targeted for Vaccine

August 31, 2020

The COVID-19 pandemic triggered by the SARS-CoV-2 coronavirus is causing health and economic havoc on a global scale requiring the development of an effective vaccine and therapeutics. Spike proteins found on the viral surface of SARS-CoV-2 attach to human cells to gain entry. Neutralizing antibodies which target these same spike proteins of the CoV-2 virus would effectively block viral entry.

A research team reviewed data on ~300 antibodies from convalescent patients that target SARS-CoV-2 and found that the gene IGHV3-53 was the most frequently used to produce these antibodies.

Winning the Fight against Influenza

May 31, 2019

Every year the flu vaccine contains a different formulation, due to multiple influenza virus strains and their ability to mutate. Scientists are working toward the universal flu vaccine, which would target conserved regions of the virus. Such a vaccine would be effective regardless of virus strain or genetic drift due to mutation, requiring no yearly updates. Current research focuses on the virus’s hemagglutinin (HA) stem region, which is targeted by our immune system’s broadly neutralizing antibodies (bnAbs). A team of researchers from Scripps and Janssen developed bnAbs to HA, which proved successful in preventing influenza infection in mice. Some of these are now being evaluated for effectiveness in human clinical trials. The team is now focused on finding an effective small molecule based on their bnAbs, which would have the advantage of oral delivery.

Structural Study of Potent Peptidic Fusion Inhibitors of Influenza Virus Hemagglutinin

March 30, 2018

Influenza also called “Flu” is a disease of the human respiratory tract caused by influenza virus. Each year, seasonal influenza can cause severe and widespread disease in the human population and cost billions of dollars to the world economy.  Such a problem occurred this year with the influenza A H3N2 virus. Currently available remedies to tackle influenza are the seasonal trivalent or tetravalent vaccines or FDA-approved antiviral drugs, such as Tamiflu and Relenza.

Structure of the Human Cysteine Desulfurase Complex

September 30, 2017

Iron-sulfur (Fe-S) clusters are cofactors that are required for the function of proteins in many critical cellular processes.  All living organisms synthesize and distribute Fe-S clusters using complex biosynthetic pathways. In humans, the mitochondrial cysteine desulfurase, NFS1, is responsible for the conversion of the sulfur-containing amino acid, cysteine, to alanine and persulfide sulfur, an intermediate in Fe-S cluster synthesis. In contrast to the analogous cysteine desulfurase in prokaryotes, the eukaryotic NFS1 enzyme requires accessory proteins, ISD11 and ACP, for its function. A team of scientists investigated the structure of the NFS1-ISD11-ACP complex in order to unravel NFS1’s requirement of ISD11 and ACP for function.

Structures of the CRISPR Genome Integration Complex

August 31, 2017

CRISPR, a powerful new tool that can target and change specific sequences of DNA, is based on a prokaryotic immune system response. The first step of bacterial immunity via CRISPR is placing sequences of foreign (viral) DNA between specific palindromic DNA repeats in the bacterial genome. The enzyme complex Cas1-Cas2 must target the correct DNA locus for integration, since insertion of the viral DNA into other areas of the genome may cause damage to the bacteria.

Inhibition of the Gas6/Axl Pathway Augments the Efficacy of Chemotherapies

January 31, 2017

The presence of the receptor tyrosine kinase Axl on tumor cells is correlated with disease severity and thus is an important oncology target. Developing inhibitors to Axl has been met with limited success due to the tight affinity with which Axl binds its ligand, growth arrest-specific 6 (Gas6). Researchers have engineered a soluble “receptor decoy,” called MYD1, based on Axl’s ligand-binding domain, that binds Gas6 even more tightly than Axl does.  

Structure of the Cell’s DNA Gatekeeper

August 31, 2016

The nucleus, which contains the DNA in eukaryotic cells, has pores in the surrounding double membrane that actively transport biologically important molecules in and out. Controlling these processes is done by a macromolecular protein machine called the nuclear pore complex (NPC). The human NPC is very large, composed of around 1000 proteins of 34 different types, which assemble into a structure with eight-fold symmetry. Because of the important role the NPC plays in our cells and its role in various diseases, such as viral infections, cancers, and neurodegenerative diseases, researchers would benefit from a high-resolution structure of the NPC that reveals the ordering of all of its ~10 million atoms. A team of scientists has accomplished exactly this.

A New Type of Pilus from the Human Microbiome

July 29, 2016

Many bacteria, including many colonizing our own gut biomes, produce hair-like pili structures on their surfaces. There are various types of pili used for different purposes, like exchanging genetic information (conjugation), movement, and adhesion. A bacterium builds pilus through oligomerization of protein subunits. A group of scientists have determined the structure of a new type of pilus, which they named the type V pilus.

Structure, Inhibition and Regulation of Two-pore Channel TPC1 from Arabidopsis thaliana

March 31, 2016

Filoviruses, such as Ebola virus require host-cell receptors, endocytosis, proteolytic cleavage, and fusion with the endolysosomal membrane for release of viral material into the cytoplasm. Two-pore channels (TPCs) comprise a subfamily (TPC1-3) of eukaryotic voltage- and ligand-gated cation channels that contain two non-equivalent tandem pore-forming subunits that then dimerize to form quasi-tetramers and orchestrate the trafficking of Filoviruses, including Ebola, in human cells.

Discovery of Next Generation RAF Inhibitors that Dissociate Paradoxical Activation from Inhibition of the MAPK Pathway

February 29, 2016

Mutation of the gene coding for the BRAF kinase, an important enzyme in the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway, can lead to melanoma, an aggressive skin cancer. The pharmaceutical company Plexxikon has developed drugs, like vemurafenib, that treat metastatic melanoma harboring BRAF mutation.

Revealing a New Conformational State in a Chloride/Proton Exchanger

January 29, 2016

Ion transport across the hydrophobic barrier of the cell membrane is central to life.  Biological membranes are hydrophobic barriers that are impermeable to ionic species. Thus, ionic movements across these membranes require catalysis by specific proteins situated at the membranes such as ion channels and transporters. CLC transporters are such proteins that facilitates transport of chloride (Cl-) and protons (H+) across biological membranes.

Crystal Structures of the Synaptotagmin-SNARE Complex that is Essential for Synchronous Synaptic Neurotransmitter Release

October 31, 2015

Scientists have determined the 3-D structure of a complex of synaptic proteins that controls the release of signaling chemicals from brain cells in less than one-thousandth of a second, which ultimately could help unlock a new realm of drug research targeting brain disorders.

Goniometer-based Femtosecond Macromolecular Crystallography

October 31, 2015

Scientists have developed a goniometer-based system to study radiation-sensitive macromolecular complexes.

Reversible CO-binding to the Active Site of Nitrogenase

March 31, 2015

As a basic biological building block of amino acids and DNA, nitrogen is necessary for life. Yet most of the Earth’s nitrogen is contained in the atmosphere as dinitrogen, which most organisms are unable to use because they cannot break dinitrogen’s N-N-triple bond. A few microorganisms, however, are able to use an enzyme called nitrogenase to catalyze the transformation of dinitrogen into bioavailable ammonia.

Antibody Recognition of the Influenza Hemagglutinin by Receptor Mimicry

November 30, 2014

Influenza viruses infect millions of people each year, cause severe illness, and present a significant health challenge. Vaccines are effective in preventing the flu but they require almost yearly reformulation to keep up with the constantly changing viruses. The highly variable hemagglutinin (HA), the major surface glycoprotein on influenza viruses, binds host cells to initiate infection. Scientists have identified a broadly neutralizing antibody, F045-092, that can inhibit this binding.

Fatty Acid Biosynthesis Caught in the Act

March 31, 2014

Fatty acids are key components of a variety of biological functions ranging from cellular membranes to energy storage. In addition, they are of great interest as potential “green” biofuels and targets in the development of novel antibiotics. In order to fully exploit their potential, researchers must first understand in detail how organisms synthesize fatty acids. However, due to the dynamic nature of the process, structural and functional studies of fatty acid biosynthesis are very challenging. A team of scientists has recently made a giant leap forward by determining the structure of a protein–protein complex that represents a snapshot of fatty acid biosynthesis in action.

Structure of Chinese Herbal-based Medicine Captured by ATP on a Human tRNA Synthetase

October 31, 2013

For approximately 2,000 years, the Chinese have been using the Chang Shan herb to treat malaria-induced fevers. A derivative of the herb’s active ingredient has also been utilized in clinical trials for cancer and other therapies. Previous studies showed that the derivative, called halofuginone (HF), binds to an enzyme known as prolyl-tRNA synthetase (ProRS). Inhibition of ProRS by HF requires the additional presence of adenosine triphosphate (ATP), interestingly one of ProRS’s three native substrates. Recent studies have shed new light on the structural interplay of ProRS, HF and ATP.

Structure of the DUF2233 Domain in Bacteria and the Stuttering-associated UCE Glycoprotein

July 31, 2013

UCE plays a key role in the functioning of lysosomes, cellular sacs full of digestive enzymes that break down bacteria, viruses and worn-out cell parts for recycling. When this recycling process goes awry, it can cause rare metabolic diseases such as Tay-Sachs and Gaucher, which often cause death in affected children by their early teens. Three years ago, researchers discovered that three mutations in UCE itself were linked to persistent stuttering that is passed down in families.

The Structure and Dynamics of Eukaryotic Glutaminyl-tRNA Synthetase

May 31, 2013

Aminoacyl-tRNA synthetases are required in all three domains of life to add the correct amino acid to its cognate tRNA, an essential step in protein synthesis. Despite their importance, no structure had been reported for any full-length eukaryotic, glutaminyl-tRNA synthetase (GlnRS), although structural data for two prokaryotic GlnRS species exists.

Allosteric Activation and Modulation of Pentameric Ligand-gated Ion Channels

April 30, 2013

Cys-loop receptors in eukaryotic cells control fast synaptic transmission and are important targets for various therapeutics which include general anesthetics. Although technical challenges have limited the determination of high-resolution structures for Cys-loop receptors, researchers from the University of Pittsburgh School of Medicine have taken advantage of two homologous proteins: the pentameric ligand-gated ion channels (pLGICs) found in the bacterium Erwinia chrysanthemi (ELIC) and the cyanobacterium Gloebacter violaceus (GLIC). The researchers carried out crystallographic studies of these pLGICs on SSRL Beam Line 12-2, investigating the structural underpinnings of the pLGIC activation process and the structural basis of anesthetic modulation of pLGICs.

The Lassa Virus Nucleoprotein Appears to Exhibit Conformational Control of Genome Binding

January 31, 2013

Lassa virus is endemic in Western Africa, and is the most common cause of viral hemorrhagic fever, infecting an estimated 300,000-500,000 people annually. It is also the hemorrhagic fever most frequently transported out of Africa to the United States and Europe. Understanding the key proteins of Lassa virus and any Achilles’ Heels written into their protein structures will enable development of therapeutics for medical defense. Recent analysis of the crystal structure of the virus’ RNA binding domain done at SSRL may have revealed one promising area of vulnerability.

Structural Basis of Wnt Recognition by Frizzled

September 24, 2012

Wnt proteins engage an array of receptors and inhibitors to precisely regulate crucial processes during embryonic development and tissue homeostasis and repair in the adult, and deregulated Wnt signaling is observed in many types of cancers and degenerative diseases.

Folate Binding Site of Flavin-dependant Thymidylate Synthase and the Mechanistic Implications

September 24, 2012

Flavin-dependant thymidylate synthases (FDTSs) are a class of recently identified family of thymidylate synthases that employ novel mechanism for the thymidylate synthase reaction.   Thymidylate synthases use N5,N10-methylene-5,6,7,8-tetrahydrofolate (CH2H4folate) to reductively methylate 2’-deoxyuridine-5’-monophosphate (dUMP) producing 2’-deoxythymine-5’-monophosphate (dTMP).  dTMP is one of the four DNA building blocks and is crucial for survival of all organisms.  Unlike other deoxynucleotides, dTMP cannot be directly synthesized by a ribonucleotide reductase, and its de novo biosynthesis requires the enzyme thymidylate synthase. Therefore, inhibition of thymidylate synthesis stops DNA production, arresting cell cycle and eventually leading to “thymineless” cell death.  The human enzyme has long been recognized as a target for anticancer drugs.

Since FDTS enzymes are mainly found in very pathogenic microbes including the pathogens causing leprosy, botulism, diarrhea, anthrax, pneumonia, syphilis, etc., the FDTS enzyme is an attractive target for antibiotic drugs.

Computational Design of Anti-flu Proteins

August 31, 2012

Understanding the physical underpinnings of how proteins interact specifically with one another and not with the myriad other molecules that coexist in every cellular compartment is a major goal of molecular biology. The broad outlines of an answer were suggested by Linus Pauling in the 1940’s: the aggregate effect of numerous weak and nonspecific van der Waals, hydrogen-bonding, and electrostatic interactions underlie high specificity and affinity. Since Pauling’s days thousands of co-crystal structures have provided concrete examples for how molecular recognition is achieved in different biological contexts. Yet, the ultimate proof for understanding a natural phenomenon lies in recapitulating it; in the words of Thomas Edison, ‘until man duplicates a single blade of grass, Nature laughs at his so-called scientific knowledge’.

The Crystal Structure of a-Thrombin in Complex with Platelet Glycoprotein (GP) Iba

January 30, 2004

When a blood vessel is cut, the body activates a repair mechanism that eventually seals the cut and prevents further blood loss. This life saving process becomes life threatening when clots form inside a functional blood vessel. Arrest of bleeding works through platelet adhesion and thrombin-induced fibrin formation at the site of injury. In order for the platelets to stick to the injured tissues and to each other, they need to be activated. Thrombin is an essential protease (a type of enzyme) that activates platelets and forms blood clots in response to vascular injury.

Synaptic Arrangement of the Neuroligin/b-Neurexin Complex Revealed by X-ray and Neutron Scattering

September 26, 2007

Autism is considered among the most devastating neurological disorder conditions of early childhood. Now, researchers working in part at SSRL's Beam Line 4-2 have determined a three-dimensional structural model of a complex with the only two extracellular synaptic proteins implicated in autism spectrum disorders and mental retardation. Such a finding could deepen our understanding of this mysterious and debilitating type of disorder. The findings were published in the June 2007 edition of the journal Structure.

MitoNEET is a Uniquely Folded Outer Mitochondrial Membrane Protein Stabilized by Diabetes Drugs

October 31, 2007

The rise in obesity in the United States parallels a dramatic increase in obesity-associated diseases, most notably type-2 diabetes. This disease is predicted to reach epidemic proportions in the next several decades (Zimmet et al 2001, Urek et al 2007). Thus, understanding the biochemical processes underlying type-2 diabetes and identifying new targets for therapeutic intervention are critical for national and world health.

The Structures of Synaptic Cell Adhesion Proteins Neuroligin-1 in Isolation and in Complex with Neurexin-1b Reveal Specific Protein-Protein and Protein-Ca2+ Interactions

December 20, 2007

Autism is a neurodevelopmental disorder that impairs social interactions, and causes communication deficits and repetitive behaviors. About 1 in every 150 children is affected by autism. Genetic screens revealed that mutations in the neurexin and neuroligin genes are among the multiple genetic causes of autism spectrum disorders and mental retardation (Jamain et al., 2003; Szatmari et al., 2007).

Structures of the GRP94-Nucleotide Complexes Reveal Mechanistic Differences between the Hsp90 Chaperones

January 30, 2008

Life depends on the biochemical activity of the thousands of proteins that inhabit and decorate the surface of every one of our cells. Proteins themselves, although simple linear combinations of the twenty amino acids, derive their remarkable properties from the complex three-dimensional structures into which they fold. In this way, enzyme active sites are created, protein-protein recognition surfaces are formed, and the chemistry of life is set in motion.

Snapshots of the IL-4 Receptor Ternary Complexes: An Opportunity to Visualize the Basis of Cytokine Receptor Pleiotropy in the Immune System

April 29, 2008

Stanford University School of Medicine scientists working in part at SSRL's Beam Line 11-1 have uncovered new molecular insights to the mechanism behind immune disorders such as asthma. Using protein x-ray crystallography at 3.0 Angstrom resolution, researchers Sherry LaPorte and Chris Garcia solved three structures of two signaling proteins known as "cytokines" in complex with their shared receptors, where these molecules help regulate immune system activity. The study was published as the cover story in the January 25 edition of the journal Cell.

Structure of the TGF-β Receptor Complex Reveals Evolutionary Adaptations that have Led to Diversification of Function within the Superfamily

May 30, 2008

TGF-beta is the founding member of a large family of biological molecules important in regulating cellular growth and differentiation, both in embryos as well as adults. Now, using x-ray diffraction at SSRL Beam Line 11-1 for macromolecular crystallography, Groppe, Hinck, and colleagues from the University of Texas Health Science Center at San Antonio have determined the structure of TGF-beta in complex with two of its cellular receptors, a finding that could lead to new insight as to how it functions as a suppressor of cell growth and as a stimulator of cell differentiation, processes which go awry in diseases such as cancer. The results are published in the February 1 edition of Molecular Cell.

Structure of the Ebola Virus Glycoprotein Bound to an Antibody from a Human Survivor

November 25, 2008

Using macromolecular crystallography techniques, the team solved the structure of a protein on the Ebolavirus's surface, called glycoprotein GP, in complex with a rare antibody identified in a human survivor. The glycoprotein-antibody complex proved especially challenging to crystallize and subsequently, to yield well-diffracting crystals. The team grew ~50,000 crystal samples and screened 800 of the largest, using in part the highly-automated robotics hardware and software at the SSRL beam lines, before finding a sample that would diffract to 3.4 Angstroms.

A Golden Ruler Used to Measure DNA Structure in Solution

December 17, 2008

DNA is softer and stretchier than previously believed, at least on the short length scales of up to 20 base pairs. This finding is the result of a recent study conducted in part at SSRL's biological small-angle x-ray scattering Beam Line 4-2 by a team of researchers from Stanford University. The results were published in the October 17 edition of the journal Science.

Structural and Functional Basis for Broad-spectrum Neutralization of Avian and Human Influenza Viruses

March 30, 2009

Scientists have recently identified a family of human antibodies that can take out an unprecedented number of different types of flu viruses, including H5N1 'bird flu' and the 1918 H1N1 'Spanish flu', which killed millions around the world during World War I, as well as seasonal flu. Using SSRL's Beam Line 9-2, Dr. Robert Liddington from the Burnham Institute for Medical Research led a team of scientists that determined the crystal structure of one such antibody, F10, in complex with the hemagglutinin H5 to unveil the molecular mechanism of virus neutralization. Results were published online 22 February 2009 in the journal Nature Structural and Molecular Biology.

Crystal Structure of the Hexameric Assembly Unit of the HIV Capsid

January 25, 2010

The genome of the human immunodeficiency virus (HIV-1) is bundled inside a capsid composed of about 1,500 copies of the viral Capsid Assembly (CA) protein. These proteins first assemble into substructures, each with six proteins, and these substructures come together to create the cone-shape casing of the virus. Disruption of capsid formation is a natural target for HIV therapies, and knowing the atomic structure of the CA proteins in the capsid would be useful for drug development. However, inherent flexibility in these molecules makes obtaining quality crystals difficult.

Structure of an N-terminal Tα Peptide Inserted into a Hydrophobic Pocket of the Mammalian C. elegans Homolog, UNC119

April 16, 2012

In order for our eyes to see in both intense and low light conditions, molecular mechanisms allow for light and dark adaptation. The G-protein transducin is responsible for transducing signal from the photon receptor protein rhodopsin in rod and cone photoreceptors of our retina. Transducin is composed of three polypeptides, α, β and γ. The α subunit contains the GTP binding site. While waiting for a signal from rhodopsin, transducin is bound to the outer segment of the neuron. During exposure to normal daylight, transducin becomes displaced and migrates to another part of the cell: the photoreceptor is adapting to light. In darkness or very dim light, transducin will return to its “home” membrane. 

How a Single Receptor Discriminates between a Variety of Different Ligands

April 30, 2012

Cytokines are central to the innate immune system. Type I interferons (IFNs) are a kind of cytokine signaling protein that is important for cellular communication, regulating diverse cellular processes.  Showing surprising economy, just one receptor is responsible for binding a variety of IFNs, each with differing functions.

Time-Resolved Small-Angle X-ray Scattering Studies Revealed Three Kinetic Stages of a T=4 Virus Maturation

June 28, 2010

The capsid that surrounds viruses is formed from subunit proteins that interact in specific ways to form a tight shell. The processes of coming together and forming interactions are multistep and complex and are fundamental events to acquire viral infectivity. The capsid maturation process of the Nudaurelia capensis omega virus includes pH-dependant conformational changes and auto-proteolysis. Like many human viruses such as HIV and herpes virus, NwV, an insect virus, requires these specific structural changes to become infectious.

Spotting Disease Hot Spots in Ryanodine Receptors

November 29, 2010

Our bodies heavily rely on calcium ions (Ca2+). Their concentration in the cell cytoplasm is normally low under resting conditions, and its influx through specialized ion channels drives many functions ranging from muscle contraction, regulating heart beats, secretion of hormones and neurotransmitter, transcription of specific genes, and more. Ca2+ can enter the cytoplasm either from the extracellular space, or from intracellular stores.

Easy to Get In, Hard to Get Out: X-ray Structure and Mechanism of RNA Polymerase II Stalled at an Antineoplastic Monofunctional Platinum-DNA Adduct

January 31, 2011

Cisplatin, a platinum-based anti-cancer drug, is a widely-used and effective cancer chemotherapy drug. It slows the growth of cancer cells by inhibiting transcription through DNA modification, creating chemical links that serve as a roadblock as the polymerase attempts to transcribe the DNA into RNA.

Subscribe to Biomedical Sciences